Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers

• US 6,007,845 A
• Filed: 03/25/1996
• Issued: 12/28/1999
• Est. Priority Date: 07/22/1994
• Status: Expired due to Term

• Current Assignee: Massachusetts Institute of Technology
• Original Assignee: Massachusetts Institute of Technology
• Inventors: Minamitake, Yoshiharu, Gref, Ruxandra, Peracchia, Maria Teresa, Langer, Robert S., Domb, Abraham J.
• Primary Examiner(s): Smith, Lynette R. F.
• Assistant Examiner(s): LEE, DATQUAN HUU
• Application Number:
  US08/582,993
• Time in Patent Office: 1,373 Days
• Field of Search: 424/78.08, 424/462, 424/451, 424/502, 424/498, 424/489, 424/497, 424/1-11, 424/9.4, 424/9.411, 424/9.5, 424/452, 514/772.3, 514/784, 514/963, 514/402.21, 428/402.21, 428/402.24, 428/403
• US Class Current: 424/501
• CPC Class Codes: A61K 9/5153 Polyesters, e.g. poly(lactide-co-glycolide)
• CPC Class Codes: Y10T 428/2985 Solid-walled microcapsule from synthetic polymer
• CPC Class Codes: Y10T 428/2989 Microcapsule with solid core [includes liposome]

Abstract

Particles are provided that are not rapidly cleared from the blood stream by the macrophages of the reticuloendothelial system, and that can be modified to achieve variable release rates or to target specific cells or organs. The particles have a core of a multiblock copolymer formed by covalently linking a multifunctional compound with one or more hydrophobic polymers and one or more hydrophilic polymers, and contain a biologically active material. The terminal hydroxyl group of the poly(alkylene glycol) can be used to covalently attach onto the surface of the particles biologically active molecules, including antibodies targeted to specific cells or organs, or molecules affecting the charge, lipophilicity or hydrophilicity of the particle. The surface of the particle can also be modified by attaching biodegradable polymers of the same structure as those forming the core of the particles. The typical size of the particles is between 180 nm and 10,000 nm, preferably between 180 nm and 240 nm, although microparticles can also be formed as described herein. The particles can include magnetic particles or radiopaque materials for diagnostic imaging, biologically active molecules to be delivered to a site, or compounds for targeting the particles. The particles have a prolonged half-life in the blood compared to particles not containing poly(alkylene glycol) moieties on the surface.

Claims

1. Multiblock copolymers comprising a multifunctional compound covalently linked to at least three polymer blocks, wherein the polymer blocks comprise one or more hydrophilic polymers and one or more hydrophobic bioerodible polymers.

2. The multiblock copolymer of claim 1 wherein the multifunctional compound is selected from the group consisting of dextrins, pentaerythritol, glucaronic acid, tartaric acid, mucic acid, citric acid, benzene tricarboxylic acid, benzene tetracarboxylic acid and butane diglycidyl ether.

3. The multiblock copolymer of claim 1 wherein the hydrophilic polymer is selected from the group consisting of polyalkylene glycols, polyvinyl alcohols, polypyrrolidones, poly(amino acids), oxidized cellulose and dextrans.

4. The multiblock copolymer of claim 3 wherein the poly(amino acids) are selected from the group consisting of gelatin, fibrinogen and albumin fragments.

5. The multiblock copolymer of claim 1 wherein the hydrophobic polymer is selected from the group consisting of polyphosphazenes, polyphosphate esters, polyanhydrides, polyhydroxybutyric acid, polyorthoesters, polycaprolactone, poly(α

-hydroxy acids), polybutylene glycol and copolymers prepared from the monomers of these polymers.

6. A particle having a diameter of between 50 nm and 1000 μ

m formed of or coated with a multiblock copolymer formed by covalently linking a multifunctional compound to at least three polymer blocks, wherein the polymer blocks comprise one or more hydrophilic polymers and one or more hydrophobic bioerodible polymers to form a coblock polymer.

7. The particle of claim 6 further comprising a substance to be delivered selected from the group consisting of peptides, proteins, carbohydrates, nucleic acids, lipids, polysaccharides, combinations thereof, and synthetic inorganic or organic molecules that cause a biological effect when administered to an animal.

8. The particle of claim 6 wherein the hydrophilic polymer is selected from the group consisting of polyalkylene glycols, polyvinyl alcohols, polypyrrolidones, poly(amino acids), oxidized cellulose and dextrans.

9. The particle of claim 8 wherein the poly(amino acid) is selected from the group consisting of gelatin, fibrinogen and albumin fragments.

10. The particle of claim 8 wherein the polyalkylene glycol is selected from the group consisting of polyethylene glycol and polyoxyethylene/polyoxypropylene copolymers.

11. The particle of claim 6 wherein the hydrophobic polymer is selected from the group consisting of polyphosphazenes, polyphosphate esters, polyanhydrides, polyhydroxybutyric acid, polyorthoesters, polycaprolactone, poly(α

-hydroxy acids) and copolymers prepared from the monomers of these polymers.

12. The particle of claim 6 wherein the multifunctional compound is selected from the group consisting of dextrins, pentaerythritol, glucaronic acid, tartaric acid, mucic acid, citric acid, benzene tricarboxylic acid, benzene tetracarboxylic acid and butane diglycidyl ether.

13. The particle of claim 6 comprising molecules covalently bound to the surface of the particle via reactive groups on the hydrophilic polymer, wherein the molecules are selected from the group consisting of biologically active molecules, non-biologically active molecules which can be detected, targeting molecules, and molecules affecting the charge, lipophilicity or hydrophilicity of the particle.

14. The particle of claim 13, wherein the targeting molecule is selected from the group consisting of compounds specifically reactive with a cell surface component, antibodies and antibody fragments.

15. The particle of claim 6 wherein the diameter is less than one micron.

16. The particle of claim 6 wherein the diameter is between one and 1000 microns.

17. The particle of claim 13 wherein the detectable molecule is selected from the group consisting of substances detectable by x-ray, fluorescence, ultrasound, magnetic resonance imaging and radioactivity.

18. The particle of claim 8, wherein the poly(alkylene glycol) is poly(ethylene glycol).

19. The particle of claim 6 formed of a core of a different material than the coblock polymer coating.

20. A method for making a multiblock copolymer by covalently linking a multifunctional compound to at least three polymer blocks, wherein the polymer blocks comprise one or more hydrophilic polymers and one or more hydrophobic bioerodible polymers.

21. The method of claim 20 further comprising forming a particle with a diameter between 50 nm and 1000 μ

m of the coblock polymer or coating a particle with a diameter between 50 nm and 1000 μ

m with the coblock polymer.

22. The method of claim 21 further comprising incorporating a substance in the particle.

23. The method of claim 22 wherein the substance is a biologically active substance selected from the group consisting of peptides, proteins, carbohydrates, nucleic acids, lipids, polysaccharides, combinations thereof, and synthetic inorganic or organic molecules that cause a biological effect when administered in vivo to an animal.

24. The method of claim 20 wherein the hydrophilic polymer is selected from the group consisting of polyalkylene glycols, polyvinyl alcohols, polypyrrolidones, poly(amino acids), oxidized cellulose and dextrans.

25. The method of claim 24 wherein the poly(amino acid) is selected from the group consisting of gelatin, fibrinogen and albumin fragments.

26. The method of claim 20 wherein the hydrophobic polymer is selected from the group consisting of polyphosphazenes, polyphosphate esters, polyanhydrides, polyhydroxybutyric acid, polyorthoesters, polycaprolactone, poly(α

-hydroxy acids) and copolymers prepared from the monomers of these polymers.

27. The method of claim 20 wherein the multifunctional compound is selected from the group consisting of dextrins, pentaerythritol, glucaronic acid, tartaric acid, mucic acid, citric acid, benzene tricarboxylic acid, benzene tetracarboxylic acid and butane diglycidyl ether.

28. The method of claim 21 further comprising covalently binding to the surface of the particle via the terminal hydroxyl group of the poly(alkylene glycol) molecules selected from the group consisting of biologically active molecules, non-biologically active molecules which can be detected, targeting molecules, and molecules affecting the charge, lipophilicity or hydrophilicity of the particle.

29. The method of claim 28 further comprising targeting the particle for delivery to a specific cell type by attaching to the surface of the particle a targeting molecule selected from the group consisting of compounds specifically reactive with a cell surface component, antibodies and antibody fragments.

30. The method of claim 28 wherein the molecule is a substance detectable by x-ray, fluorescence, magnetic resonance imaging, ultrasound or radioactivity.

37. The method of claim 22 further comprising delivering a substance to a patient comprising administering the particle to the patient,

wherein the substance to be delivered is a biologically active substance selected from the group consisting of peptides, proteins, carbohydrates, nucleic acids, lipids, polysaccharides, combinations thereof, synthetic inorganic molecules that cause a biological effect when administered in vivo to an animal and synthetic organic molecules that cause a biological effect when administered in vivo to an animal.

38. The method of claim 37, wherein the molecule is selected from the group consisting of substances detectable by x-ray, fluorescence, ultrasound, magnetic resonance imaging and radioactivity.

31. A method for delivering a substance to a patient comprising administering to the patient a particle having a diameter of between 50 nm and 1000 μ

m,

wherein the particle is formed of or is coated with a multiblock copolymer, the multiblock copolymer comprises a multifinctional compound covalently bound to at least three polymer blocks, wherein the polymer blocks comprise one or more hydrophilic polymers and one or more hydrophobic bioerodible polymers.

32. The method of claim 31 wherein the substance to be delivered is a biologically active substance selected from the group consisting of peptides, proteins, carbohydrates, nucleic acids, lipids, polysaccharides, combinations thereof, synthetic inorganic molecules that cause a biological effect when administered to an animal and synthetic organic molecules that cause a biological effect when administered to an animal.

33. The method of claim 31 wherein the hydrophilic polymer is selected from the group consisting of polyalkylene glycols, polyvinyl alcohols, polypyrrolidones, poly(amino acids), oxidized cellulose and dextrans.

34. The method of claim 33 wherein the polyalkylene glycol is selected from the group consisting of polyethylene glycol and polyoxyethylene/polyoxypropylene copolymers.

35. The method of claim 31 wherein the hydrophobic polymer is selected from the group consisting of polyphosphazenes, polyphosphate esters, polyanhydrides, polyhydroxybutyric acid, polyorthoesters, polycaprolactone, poly(α

-hydroxy acids) and copolymers prepared from the monomers of these polymers.

36. The method of claim 31 wherein the multifunctional compound is selected from the group consisting of dextrins, pentaerythritol, glucaronic acid, tartaric acid, mucic acid, citric acid, benzene tricarboxylic acid, benzene tetracarboxylic acid and butane diglycidyl ether.